Many studies used BDNF level for clinical correlations or outcome predictions in various neurological and psychiatric diseases, such as Alzheimer disease (68, 69), Parkinson disease (70), Huntington disease (71), major depressive disorder (72), and multiple sclerosis (73, 74). This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.